Back to Gene
MTR gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

MTR gene

The MTR gene provides instructions for making the enzyme methionine synthase, which is essential for processing amino acids in the body.

Normal Function

The MTR gene provides instructions for making an enzyme called methionine synthase. This enzyme plays a role in processing amino acids, the building blocks of proteins. Specifically, methionine synthase carries out a chemical reaction that converts the amino acid homocysteine to another amino acid called methionine. The body uses methionine to make proteins and other important compounds. To function properly, methionine synthase requires methylcobalamin (a form of vitamin B12) and another enzyme called methionine synthase reductase, which is produced from the MTRR gene.

Health Conditions Related to Genetic Changes

Homocystinuria

More than 20 mutations in the MTR gene have been identified in people with homocystinuria. Many of these mutations lead to the production of an abnormally small, nonfunctional version of methionine synthase. Other mutations change single amino acids in the enzyme. One of the most common mutations replaces the amino acid proline with the amino acid leucine at position 1173 (written as Pro1173Leu or P1173L), resulting in an enzyme with reduced function. Without functional methionine synthase, homocysteine cannot be converted to methionine. As a result, homocysteine builds up in the bloodstream, and the amount of methionine is reduced. Some of the excess homocysteine is excreted in urine.

Other disorders

A specific version (variant) of the MTR gene, written as A2756G, has been associated with various health problems before birth. This variant replaces the nucleotide adenine with guanine at a certain location in the gene.

  • Neural tube defects: This variant has been associated with an increased risk of birth defects that occur during the development of the brain and spinal cord.
  • Down syndrome: Some studies have suggested that the variant increases the risk of having a child with Down syndrome, though other studies have found no increased risk.

Other Names for This Gene

  • 5-methyltetrahydrofolate-homocysteine methyltransferase 1
  • 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
  • cblG
  • cobalamin-dependent methionine synthase
  • Homocysteine-methyl tetrahydrofolate methyltransferase
  • METH_HUMAN
  • Methionine Synthase
  • Tetrahydropteroylglutamate Methyltransferase

Frequently Asked Questions

Symptoms such as developmental delay, short stature, lens dislocation, skeletal abnormalities, and a history of thromboembolic events may raise suspicion for homocystinuria caused by an MTR mutation. Blood tests showing elevated homocysteine and low methionine levels are typical findings.
Yes. High‑dose methylcobalamin (a form of vitamin B12) and folic acid can improve enzyme activity in some patients, lowering homocysteine. Vitamin B6 is also used in cases where the mutation allows partial responsiveness. Regular monitoring of homocysteine levels guides dosage adjustments.
Diagnosis is confirmed by sequencing the MTR gene to identify pathogenic variants, often combined with biochemical testing (plasma homocysteine and methionine levels). A family history of homocystinuria or related symptoms can also guide testing.
low‑methionine, high‑cysteine diet is usually prescribed. Foods high in methionine (red meat, eggs, dairy) should be limited, while ensuring adequate protein from plant sources. Vitamin B6, folate, and vitamin B12 supplementation are also essential to help reduce homocysteine levels.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA